SIGMA LABS, INC.·4

Jul 6, 7:03 PM ET

Fisher Ronald Kenneth Jr 4

4 · SIGMA LABS, INC. · Filed Jul 6, 2022

Insider Transaction Report

Form 4
Period: 2022-07-01
Fisher Ronald Kenneth Jr
Vice President of Business Dev
Transactions
  • Award

    Stock Option (right to buy)

    2022-07-01+5,7365,736 total
    Exercise: $2.50Exp: 2027-07-01Common Stock (5,736 underlying)
  • Award

    Stock Appreciation Right

    2022-07-01+87,33587,335 total
    Exercise: $1.30Exp: 2027-07-01Common Stock (87,335 underlying)
Footnotes (2)
  • [F1]The stock option vests, as follows: (i) 1,434 shares subject to the option vested on the date of grant, and (ii) the remaining 4,302 shares will vest in equal (as nearly as possible) monthly installments over the succeeding 36 months, subject, in each case, to the Reporting Person remaining an employee of the Issuer on the applicable vesting date.
  • [F2]The stock appreciation right ("SAR") is payable in cash only, and vests on March 15, 2025, subject to the Reporting Person being in the continuous employ of the Issuer on the vesting date.

Documents

1 file
  • 4
    ownership.xmlPrimary